Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension
Clinical trial NCT05968430 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05968430
- Sponsor
- Mineralys Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-14
- Primary completion
- 2025-12-30
- Enrollment
- 1076
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.